Dried blood spot testing revealed markedly decreased β-glucocerebrosidase activity (<2.3 μmol/L/h), and subsequent GBA gene sequencing confirmed a pathogenic homozygous c.1226A>G (p.Asn409Ser) variant, consistent with type 1 Gaucher disease. This evidence concerns the gene GBA1 and Gaucher disease type 1.